Trump held notes of Tesla's pricing structure as he personally endorsed ... the symptoms and causes of congenital cytomegalovirus Do You Talk to Yourself? Here's What Science Says About Your ...

The biotechnology sector is gaining new momentum with better market conditions, cutting-edge innovations, and growing ...

Checkpoint Therapeutics, Inc. ("Checkpoint”) (Nasdaq: CKPT), a commercial-stage immunotherapy and targeted oncology company, ...

Checkpoint Therapeutics, Inc. ("Checkpoint") (Nasdaq: CKPT), a commercial-stage immunotherapy and targeted oncology company, today announced financial ...

We recently compiled a list of the 12 Most Promising Biotech Stocks According to Wall Street Analysts. In this article, we ...

CAMBRIDGE, Mass., March 25, 2025--2seventy bio, Inc. (Nasdaq: TSVT), today reported financial results and recent highlights ...

According to the firm, biotech equities have tremendous upside potential and an “option-like structure,” particularly when interest rates decline. Analysts at JPMorgan anticipate a recovery in ...

Discover how RNA therapeutics are reshaping medicine, offering new treatments for previously undruggable targets.

It is evaluating multiple candidates in late-stage studies, including mRNA-4157/V940 (individualized neoantigen therapy), mRNA-1647 (cytomegalovirus [CMV] vaccine) and mRNA-1010 (influenza vaccine).

Herpesvirus-encoded microRNAs (v-miRNAs) play a crucial role in modulating host cellular processes to promote viral persistence, immune evasion, and pathogenesis. These v-miRNAs function by targeting ...